Inflammatory response after prehospital high-dose glucocorticoid to patients resuscitated from out-of-hospital cardiac arrest: A sub-study of the STEROHCA trial

被引:2
作者
Obling, Laust E. R. [1 ]
Beske, Rasmus P. [1 ]
Meyer, Martin A. S. [1 ]
Grand, Johannes [1 ]
Wiberg, Sebastian [1 ,2 ,3 ]
Damm-Hejmdal, Anders [4 ]
Bjerre, Mette [5 ]
Frikke-Schmidt, Ruth [3 ,6 ]
Folke, Fredrik [3 ,4 ,7 ]
Moller, Jacob E. [1 ,3 ,8 ]
Kjaergaard, Jesper [1 ,3 ]
Hassager, Christian [1 ,3 ]
机构
[1] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen OE, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Dept Cardiothorac Anesthesiol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Capital Reg Denmark, Copenhagen, Denmark
[5] Aarhus Univ, Dept Clin Med, Med Steno Aarhus Res Lab, Aarhus, Denmark
[6] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark
[7] Copenhagen Univ Hosp, Herlev Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
[8] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
关键词
Prehospital Intervention; Post-Cardiac Arrest Syndrome; Glucocorticoid; Inflammation; Cytokines; CARDIOPULMONARY; EPIDEMIOLOGY; EPINEPHRINE; DYSFUNCTION; VASOPRESSIN; MECHANISMS; COUNCIL; INJURY; CARE;
D O I
10.1016/j.resuscitation.2024.110340
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The post-cardiac arrest syndrome (PCAS) after out-of-hospital cardiac arrest (OHCA) is characterized by a series of pathological events, including inflammation. In the randomized "STERoid for OHCA" (STEROHCA) trial, prehospital high-dose glucocorticoid decreased interleukin (IL) 6 and C-reactive protein levels following resuscitated OHCA. The aim of this predefined sub-study was to assess the inflammatory response the first three days of admission. Methods: The STEROHCA trial enrolled 137 OHCA patients randomized to either a single prehospital injection of methylprednisolone 250 mg or placebo. Inflammatory markers, including pro- and anti-inflammatory cytokines, were analyzed in plasma samples, from 0-, 24-, 48-, and 72 h post-admission. Mixed-model analyses were applied using log-transformed data to assess group differences. Results: The 137 patients included in this sub-study had a median age of 67 years (57 to 74), and the 180-day survival rates were 75% (n = 51/68) and 64% (n = 44/69) in the glucocorticoid and placebo group, respectively. A total of 130 (95%) patients had at least one plasma sample available. The anti-inflammatory cytokine IL-10 was increased at hospital admission in the glucocorticoid group (ratio 2.74 (1.49-5.05), p = 0.006), but the intervention showed the strongest effect after 24 h, decreasing pro-inflammatory levels of IL-6 (ratio 0.06 (0.03-0.10), p < 0.001), IL-8 (ratio 0.53 (0.38-0.75), p < 0.001), macrophage chemokine protein-1 (MCP-1, ratio 0.02 (0.13-0.31), p < 0.001), macrophage inflammatory protein-1-beta (MIP-1b, ratio 0.28 (0.18-0.45), p < 0.001), and tumor necrosis factor-alpha (TNF-alpha, ratio 0.6 (0.4-0.8), p = 0.01). Conclusion: Administering high-dose glucocorticoid treatment promptly after resuscitation from OHCA influenced the inflammatory response with a reduction in several systemic proinflammatory cytokines after 24 h.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial
    Obling, Laust E. R.
    Beske, Rasmus P.
    Meyer, Martin A. S.
    Grand, Johannes
    Wiberg, Sebastian
    Mohr, Thomas
    Damm-Hejmdal, Anders
    Forman, Julie L.
    Frikke-Schmidt, Ruth
    Folke, Fredrik
    Moller, Jacob E.
    Kjaergaard, Jesper
    Hassager, Christian
    CRITICAL CARE, 2024, 28 (01)
  • [2] Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial
    Laust E. R. Obling
    Rasmus P. Beske
    Martin A. S. Meyer
    Johannes Grand
    Sebastian Wiberg
    Thomas Mohr
    Anders Damm-Hejmdal
    Julie L. Forman
    Ruth Frikke-Schmidt
    Fredrik Folke
    Jacob E. Møller
    Jesper Kjaergaard
    Christian Hassager
    Critical Care, 28
  • [3] Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
    Obling, Laust E. R.
    Beske, Rasmus P.
    Meyer, Martin A. S.
    Grand, Johannes
    Wiberg, Sebastian
    Nyholm, Benjamin
    Josiassen, Jakob
    Sondergaard, Frederik T.
    Mohr, Thomas
    Damm-Hejmdal, Anders
    Bjerre, Mette
    Frikke-Schmidt, Ruth
    Folke, Fredrik
    Moller, Jacob E.
    Kjaergaard, Jesper
    Hassager, Christian
    INTENSIVE CARE MEDICINE, 2023, 49 (12) : 1467 - 1478
  • [4] Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
    Laust E. R. Obling
    Rasmus P. Beske
    Martin A. S. Meyer
    Johannes Grand
    Sebastian Wiberg
    Benjamin Nyholm
    Jakob Josiassen
    Frederik T. Søndergaard
    Thomas Mohr
    Anders Damm-Hejmdal
    Mette Bjerre
    Ruth Frikke-Schmidt
    Fredrik Folke
    Jacob E. Møller
    Jesper Kjaergaard
    Christian Hassager
    Intensive Care Medicine, 2023, 49 : 1467 - 1478
  • [5] Metabolic effects of high-dose glucocorticoid following out-of-hospital cardiac arrest
    Beske, Rasmus Paulin
    Obling, Laust Emil Roelsgaard
    Meyer, Martin Abild Stengaard
    Moller, Jacob Eifer
    Kjaergaard, Jesper
    Johansson, Paer Ingemar
    Hassager, Christian
    INTENSIVE CARE MEDICINE EXPERIMENTAL, 2025, 13 (01):
  • [6] Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients
    Pedersen, Anne Toftgaard
    Kjaergaard, Jesper
    Hassager, Christian
    Frydland, Martin
    Thomsen, Jakob Hartvig
    Klein, Anika
    Schmidt, Henrik
    Moller, Jacob Eifer
    Wiberg, Sebastian
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2022, 56 (01) : 85 - 90
  • [7] The inflammatory response is related to circulatory failure after out-of-hospital cardiac arrest: A prospective cohort study
    Langeland, Halvor
    Damas, Jan Kristian
    Mollnes, Tom Eirik
    Ludviksen, Judith Krey
    Ueland, Thor
    Michelsen, Annika E.
    Loberg, Magnus
    Bergum, Daniel
    Nordseth, Trond
    Skjaervold, Nils Kristian
    Klepstad, Pal
    RESUSCITATION, 2022, 170 : 115 - 125
  • [8] Sympathoadrenal Activation and Endothelial Damage Are Inter Correlated and Predict Increased Mortality in Patients Resuscitated after Out-Of-Hospital Cardiac Arrest. A Post Hoc Sub-Study of Patients from the TTM-Trial
    Johansson, Par I.
    Bro-Jeppesen, John
    Kjaergaard, Jesper
    Wanscher, Michael
    Hassager, Christian
    Ostrowski, Sisse R.
    PLOS ONE, 2015, 10 (03):
  • [9] Early High-Dose Erythropoietin Therapy After Out-of-Hospital Cardiac Arrest A Multicenter, Randomized Controlled Trial
    Cariou, Alain
    Deye, Nicolas
    Vivien, Benoit
    Richard, Olivier
    Pichon, Nicolas
    Bourg, Angele
    Huet, Loic
    Buleon, Clement
    Frey, Jerome
    Asfar, Pierre
    Legriel, Stephane
    Narcisse, Sophie
    Mathonnet, Armelle
    Cravoisy, Aurelie
    Dequin, Pierre-Francois
    Wiel, Eric
    Razazi, Keyvan
    Daubin, Cedric
    Kimmoun, Antoine
    Lamhaut, Lionel
    Marx, Jean-Sebastien
    de la Garanderie, Didier Payen
    Ecollan, Patrick
    Combes, Alain
    Spaulding, Christian
    Barat, Florence
    Ben Boutieb, Myriam
    Coste, Joel
    Chiche, Jean-Daniel
    Pene, Frederic
    Mira, Jean-Paul
    Treluyer, Jean-Marc
    Hermine, Olivier
    Carli, Pierre
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (01) : 40 - 49
  • [10] Cardiovascular changes induced by targeted mild hypercapnia after out of hospital cardiac arrest. A sub-study of the TAME cardiac arrest trial
    Melberg, Mathias Baumann
    Flaa, Arnljot
    Andersen, Geir oystein
    Sunde, Kjetil
    Bellomo, Rinaldo
    Eastwood, Glenn
    Olasveengen, Theresa Mariero
    Qvigstad, Eirik
    RESUSCITATION, 2023, 193